A gap analysis of opportunities and priorities for breast surgical research

Oreste D. Gentilini; Jana De Boniface; Jean-Marc Classe; Florentia Peintinger; Toralf Reimer; Roland Reitsamer; Isabel Rubio; Marjolein Smidt; Thorsten Kuehn

doi:10.1016/S1470-2045(18)30916-1

A gap analysis of opportunities and priorities for breast surgical research

Oreste D. Gentilini^*, Jana De Boniface, Jean-Marc Classe, Florentia Peintinger, Toralf Reimer, Roland Reitsamer, Isabel Rubio, Marjolein Smidt, Thorsten Kuehn

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	e1
Number of pages	1
Journal	Lancet oncology
Volume	20
Issue number	1
DOIs	https://doi.org/10.1016/S1470-2045(18)30916-1
Publication status	Published - Jan 2019

Keywords

TRIAL
CANCER

Access to Document

10.1016/S1470-2045(18)30916-1

Cite this

@article{3d9d394baabe4550834e2138d42f9f27,

title = "A gap analysis of opportunities and priorities for breast surgical research",

keywords = "TRIAL, CANCER",

author = "Gentilini, \{Oreste D.\} and \{De Boniface\}, Jana and Jean-Marc Classe and Florentia Peintinger and Toralf Reimer and Roland Reitsamer and Isabel Rubio and Marjolein Smidt and Thorsten Kuehn",

year = "2019",

month = jan,

doi = "10.1016/S1470-2045(18)30916-1",

language = "English",

volume = "20",

pages = "e1",

journal = "Lancet oncology",

issn = "1470-2045",

publisher = "Elsevier Ltd",

number = "1",

}

TY - JOUR

T1 - A gap analysis of opportunities and priorities for breast surgical research

AU - Gentilini, Oreste D.

AU - De Boniface, Jana

AU - Classe, Jean-Marc

AU - Peintinger, Florentia

AU - Reimer, Toralf

AU - Reitsamer, Roland

AU - Rubio, Isabel

AU - Smidt, Marjolein

AU - Kuehn, Thorsten

PY - 2019/1

Y1 - 2019/1

KW - TRIAL

KW - CANCER

U2 - 10.1016/S1470-2045(18)30916-1

DO - 10.1016/S1470-2045(18)30916-1

M3 - Comment/Letter to the editor

SN - 1470-2045

VL - 20

SP - e1

JO - Lancet oncology

JF - Lancet oncology

IS - 1

ER -